| |
 |
FK506 Binding Proteins as Targets in Anticancer Therapy
|
| |
|
pp.651-656 (6) Authors: Simona Romano, AnnaLaura Di Pace, Antonio Sorrentino, Rita Bisogni, Luigi Sivero, Maria Fiammetta Romano |
| |
|
|
| |
|
Cell Biological Manifestations of Bisdioxopiperazines: Treatment of Human Tumor Cell Lines in Culture
|
| |
|
pp.657-660 (4) Authors: Da-Yong Lu, Ding-Ren Lu, Jian Ding |
| |
|
|
| |
|
Targeted Therapies in Metastatic Melanoma: Toward a Clinical Breakthrough?
|
| |
|
pp.661-665 (5) Authors: Fanny Julia, Luc Thomas, Charles Dumontet, Stephane Dalle |
| |
|
|
| |
|
Potential New Agents for Chronic Lymphocytic Leukemia Treatment
|
| |
|
pp.666-682 (17) Authors: Malgorzata Rogalinska, Zofia M. Kilianska |
| |
|
|
| |
|
Topoisomerase I Inhibitors in the Treatment of Primary CNS Malignancies: An Update on Recent Trends
|
| |
|
pp.683-696 (14) Authors: Joshua P. Sasine, Niramol Savaraj, Lynn G. Feun |
| |
|
|
| |
|
Discovery of Allosteric Inhibitors of Kinesin Spindle Protein (KSP) for the Treatment of Taxane-Refractory Cancer: MK-0731 and Analogs
|
| |
|
pp.697-712 (16) Authors: Christopher D. Cox, Robert M. Garbaccio |
| |
|
|
